Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

U.S. law threat pushes InMed to shut BayMedica unit, pivot to Alzheimer's drugs

Summary by stocktitan.net
BayMedica will wind down by June 30, 2026 after U.S. legislation threatened its cannabinoid sales, while InMed focuses resources on INM-901 and INM-089.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

stocktitan.netstocktitan.net

U.S. law threat pushes InMed to shut BayMedica unit, pivot to Alzheimer's drugs

BayMedica will wind down by June 30, 2026 after U.S. legislation threatened its cannabinoid sales, while InMed focuses resources on INM-901 and INM-089.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Friday, March 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

United States icon

United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal